This is a preview of subscription content, log in via an institution to check access.
REFERENCE
Simons WR, Hagan M.The cost-effectiveness of adding colesevelam hydrochloride to metformin in patients with type 2 diabetes who have not achieved optimal glycemic control. 69th Annual Scientific Sessions of the American Diabetes Association: 320 abstr. 1217-P, 5 Jun 2009. Available from: URL: http://ww2.aievolution.com
Rights and permissions
About this article
Cite this article
Colesevelam provides economic benefit in T2DM treatment. Pharmacoecon. Outcomes News 582, 4 (2009). https://doi.org/10.2165/00151234-200905820-00009
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200905820-00009